The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors
Gespeichert in:
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1931730946 | ||
| 003 | DE-627 | ||
| 005 | 20250724142501.0 | ||
| 007 | tu | ||
| 008 | 250724s2024 gw ||||| m 00| ||eng c | ||
| 035 | |a (DE-627)1931730946 | ||
| 035 | |a (DE-599)KXP1931730946 | ||
| 035 | |a (OCoLC)1528824504 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-BW | ||
| 082 | 0 | 4 | |a 616.994 |q DE-101 |
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lepper, Alisa |d 1998- |e VerfasserIn |0 (DE-588)1299246060 |0 (DE-627)1856129756 |4 aut | |
| 245 | 1 | 4 | |a The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors |c vorgelegt von Alisa Helen Lepper ; Referent: Prof. Dr. med. Jochen Utikal |
| 264 | 1 | |a Heidelberg |c 2024 | |
| 300 | |a 85 Blätter |b Illustrationen, Diagramme | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Ruprecht-Karls-Universität zu Heidelberg |d 2025 | ||
| 650 | 4 | |a Immune-related adverse events | |
| 650 | 4 | |a Immune checkpoint inhibitor | |
| 650 | 4 | |a Melanoma | |
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e AkademischeR BetreuerIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 dgs | |
| 710 | 2 | |a Universität Heidelberg |e Grad-verleihende Institution |0 (DE-588)2024349-2 |0 (DE-627)102161488 |0 (DE-576)191769517 |4 dgg | |
| 751 | |a Heidelberg |0 (DE-588)4023996-2 |0 (DE-627)106300814 |0 (DE-576)208952578 |4 uvp | ||
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Lepper, Alisa, 1998 - |t The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors |d Heidelberg, 2025 |h 1 Online-Ressource (85 Seiten) |w (DE-627)1928492711 |
| 951 | |a BO | ||
| 992 | |a 20250910 | ||
| 993 | |a Thesis | ||
| 998 | |g 1299246060 |a Lepper, Alisa |m 1299246060:Lepper, Alisa |d 60000 |d 60001 |e 60000PL1299246060 |e 60001PL1299246060 |k 0/60000/ |k 1/60000/60001/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1931730946 |e 4770719345 | ||
| BIB | |a Y | ||
| JSO | |a {"recId":"1931730946","title":[{"title_sort":"study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors","title":"The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors"}],"id":{"eki":["1931730946"]},"corporate":[{"role":"dgg","display":"Universität Heidelberg","roleDisplay":"Grad-verleihende Institution"}],"noteThesis":["Dissertation. - Ruprecht-Karls-Universität zu Heidelberg. - 2025"],"type":{"bibl":"thesis"},"origin":[{"dateIssuedDisp":"2024","dateIssuedKey":"2024","publisherPlace":"Heidelberg"}],"language":["eng"],"physDesc":[{"extent":"85 Blätter","noteIll":"Illustrationen, Diagramme"}],"person":[{"display":"Lepper, Alisa","role":"aut","given":"Alisa","roleDisplay":"VerfasserIn","family":"Lepper"},{"roleDisplay":"AkademischeR BetreuerIn","family":"Utikal","given":"Jochen","display":"Utikal, Jochen","role":"dgs"}],"name":{"displayForm":["vorgelegt von Alisa Helen Lepper ; Referent: Prof. Dr. med. Jochen Utikal"]}} | ||
| SRT | |a LEPPERALISSTUDYONMYE2024 | ||